www.researchviews.com/healthcare/pharma/. /DealReport.aspx?. Cached12 Jul 2012 . Under the agreement, Ascletis obtained exclusive license to develop Alnylam's
www.wikinvest.com/. /Alnylam. (ALNY)/Advances_Aln-vsp_Rnai_Therapeutic_Treatment_Liver_Cancer_LeadCached6 Aug 2008 . Advances ALN-VSP, an RNAi Therapeutic for the Treatment of Liver Cancer, as
www.bloomberg.com/apps/news?pid=newsarchive&sid=aabI. CachedALN-VSP was administered to over 40 patients at doses ranging from 0.1 to 1.5
www.site.co.uk/Aln-vsp-updatesCachedLatest Aln Vsp Updates News, Updates from Twitter, Images, & Videos from
dgidb.genome.wustl.edu/drug_claims/TTD/DCL001139CachedCitation: Update of TTD: Therapeutic Target Database. Zhu F, Han BC, . , Zheng
www.the-scientist.com/?articles.view/articleNo/35629/title/. CachedSimilar20 May 2013 . Known as ALN-VSP, the drug passed through Phase 1 trials earlier this year,
www.ncbi.nlm.nih.gov/pubmed/23358650Similar28 Jan 2013 . To examine the activity and safety of LNP-formulated siRNAs in humans, we
https://propthink.com/the-beginning-of-a-shift-at-tekmira-from-focus-on-delivery-to-therapy/CachedSimilar23 Apr 2013 . But more importantly, three of Alnylam's leading candidates — ALN-TTR02, ALN-
Although simple, ALN-VSP continues to produce data in favor of use in the clinic.
www.v2mediadesign.com/. /alnylam-provides-key-2012-goals-for-rnai-therapeutics-pipeline/Cached8 Jan 2012 . . for Alnylam's pipeline efforts where we demonstrated RNAi proof of mechanism
www.pipelinereview.com/. /Alnylam-Presents-New-Pre-clinical-Data-on-ALN-VSP-an-RNAi-Therapeutic-for-the-Treatment-of-Liver-Cancer. Cached18 Nov 2009 . “ALN-VSP is Alnylam's first systemic RNAi program, as well as our first clinical
files.shareholder.com/. /TKMR_News_2012_6_4_General_Releases.pdfCached4 Jun 2012 . VSP, an RNAi therapeutic for the treatment of advanced solid tumors with . The
www.cnbc.com/id/100736733Cached14 May 2013 . ALN-VSP, which is a systemically delivered RNAi therapeutic for the treatment of
ir.themedicinescompany.com/phoenix.zhtml?c=122204. Cached9 Oct 2013 . New Pre-Clinical Results Demonstrate That ALN-PCSsc Achieves Up . . virus (
www.ribolia.com/en/rnai/index.aspx?BasicClassId=565&HeadID. CachedSimilarUnder the agreement, Ascletis gained an exclusive license from Alnylam to
ALN-VSP is composed of two siRNA molecules, targeting VEGF and Eg5 (KSP),
. delivery system (systemic) Alnylam ALN-VSP liver cancers and KSP, VEGF
www.nbcnews.com/. /tekmiras-lnp-delivery-technology-enables-proof-rnai-man-clinical-activity/Cached6 Jun 2011 . The most recent ALN-VSP data was presented at the American Society of Clinical
www.biocentury.com/products/aln-vspCachedComprehensive aln-vsp portfolio, including molecular targets, MOA, partnerships,
www.nature.com/nrd/journal/v13/n8/fig_tab/nrd4359_T2.html11 Jul 2014 . N gene of RSV, ALN-RSV01, Respiratory syncytial virus, Alnylam Pharma . KSP,
www.genomeweb.com/. /alnylam-says-liver-cancer-drug-its-first-systemic-candidate-delivery-question-li14 Aug 2008 . Alnylam Pharmaceuticals last week announced that it has selected its preclinical
www.worldpharmatoday.com/. /alnylam-and-ascletis-collaborate-to-develop-aln-vsp-for-liver-cancers-in-chinaCached13 Jul 2012 . Under the agreement, Ascletis gained an exclusive license from Alnylam to
globenewswire.com/. /Tekmira-s-LNP-Technology-Enables-ALN-VSP-Clinical-Data.htmlCached4 Jun 2012 . "We are pleased to see that the data from this extension study of ALN-VSP further
www.silencejournal.com/content/1/1/14CachedSimilarFinally, ALN-VSP builds on data from animal models in which five transcripts
www.paramiloidose.com.br/. /20131111%20Alnylam%20recebe%20designacao%20especial%20d. Cached11 Nov 2013 . Alnylam plans to develop and commercialize the ALN- . for the treatment of
www.investorvillage.com/mbthread.asp?mb=11383&tid. 1Cached18 Nov 2009 . Recs: 0. Add to Favorites Send PM Ignore, news on ALNY board re ALN-VSP
aln-vsp.com/Cachedaln-vsp.com. Find the best information and most relevant links on all topics
vq96.pixub.com/lkgaCached15 Dec 2013 . Poor weather in many parts of the country is being blamed for a slowdown in.
connection.ebscohost.com/. /alnylam-presents-data-from-phase-extension-study-aln-vsp-rnai-therapeutic-treatment-liver-cancers-american-society-. 7 Jun 2012 . The article provides information on the results from the Phase I extension study of
investor.tekmirapharm.com/releasedetail.cfm?ReleaseID=679623Cached4 Jun 2012 . "We are pleased to see that the data from this extension study of ALN-VSP further
https://www.ebi.ac.uk/ebisearch/search.ebi?db=allebi&t=ALN-VSPCachedSearch results for ALN-VSP. Showing 2 results out of 2 in All results. Filter your
clinicaltrials.pharmaceutical-business-review.com/. /alnylam-pharma-concludes-patient-recruitment-in-aln-vsp-phase-i-trial-Cached1 Apr 2011 . Alnylam Pharmaceuticals has concluded patient recruitment in a multi-center,
www.thestreet.com/. /alnylam8217s-aln-vsp-abstract-published-by-american-society-of-clinical-oncology-asco.html18 May 2011 . “We are encouraged by the data from our ALN-VSP program, as they represent
www.herandkingscounty.com/. /neurodermatitis-drug-aln-vsp-betamethasone-internet-colorado-springsCachedNeurodermatitis Drug Aln-vsp - Betamethasone Internet In Colorado Springs.
stocktwits.com/BioDueDiligence/message/7794675CachedALN-VSP appears irrelevant at this point. $ALNY doesn't even mention it
https://www.flickr.com/photos/52158435@N05/4930359000/Cached26 Aug 2010 . Here is the entire post: Aln Vsp. . [url=https://www.flickr.com/photos/52158435@
www.edisoninvestmentresearch.com/. /tekmira-pharmaceuticalsCached15 Apr 2013 . . cancer) and TKM-Ebola. The LNP IP is used in Alnylam's most advanced
www.highbeam.com/doc/1G1-259529259.htmlCached21 Jun 2011 . Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics
www.finanzen.net/. /Alnylam-s-ALN-VSP-Abstract-Published-by-American-Society-of-Clinical-Oncology-ASCO-1132284Cached19 May 2011 . "We are encouraged by the data from our ALN-VSP program, as they represent
www.azonano.com/news.aspx?newsID=26490CachedSimilar1 Feb 2013 . . liver involvement, which utilizes Tekmira's lipid nanoparticle (LNP) technology.
www.bio.org/alnylam-presents-data-its-phase-i-extension-study-aln-vsp-rnai-therapeutic-treatment-liver-cancers-a4 Jun 2012 . Alnylam Presents Data from its Phase I Extension Study with ALN-VSP, an RNAi
www.fiercebiotech.com/. /alnylam-receives-clearance-fda-initiate-phase-i-study-aln-vsp-treatment-liver-cancersCachedSimilarAlnylam Receives Clearance from FDA to Initiate Phase I Study with ALN-VSP for
www.dailyfinance.com/. /alnylam-and-tekmira-restructure-relationship-and-s/Cached12 Nov 2012 . Further, Alnylam has elected to buy-down certain future potential milestone and
www.fiercebiotech.com/. /alnylam-and-ascletis-form-strategic-collaboration-develop-aln-vsp-rnai-therCachedPartnership is Focused on Developing ALN-VSP for Hepatocellular Carcinoma (
www.epvantage.com/Default.aspx?StoryID=173806Cached23 Dec 2008 . Company Files IND for ALN-VSP, an RNAi Therapeutic for the Treatment of Liver
www.pharmaceuticalonline.com/. /tekmira-partner-alnylam-files-first-ind-for-a-0001Cached6 Jan 2009 . The Alnylam product candidate, ALN-VSP, is being developed as a treatment for
www.reuters.com/. /05/. /idUS241647+18-May-2011+BW20110518Cached18 May 2011 . “We are encouraged by the data from our ALN-VSP program, as they represent
www.sharesinv.com/articles/BWC880/Cached12 Jul 2012 . Partnership is Focused on Developing ALN-VSP for Hepatocellular Carcinoma (
www.tudou.com/home/diary_v4834021.htmlCached2010年12月2日 . Now,《时代周刊》评选出七大最糟糕的发明- Qzone日志, 阿尔尼拉姆company plans
www.drugs.com/. /alnylam-s-aln-vsp-abstract-published-american-society-clinical-oncology-asco-9452.htmlCached20 May 2010 . “We are encouraged by the results we have seen with ALN-VSP in this Phase I